Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers.

Source:http://linkedlifedata.com/resource/pubmed/id/12538852

Proc. Natl. Acad. Sci. U.S.A. 2003 Feb 4 100 3 1250-5

Download in:

View as

Triples

General Info

PMID
12538852